File Download
 
 
Supplementary

Postgraduate Thesis: A systematic review of the drug sorafenib in extending survival time in patients with hepatocellular carcinoma
  • Basic View
  • Metadata View
  • XML View
TitleA systematic review of the drug sorafenib in extending survival time in patients with hepatocellular carcinoma
 
AuthorsWong, Carmen
黃嘉敏
 
Issue Date2011
 
PublisherThe University of Hong Kong (Pokfulam, Hong Kong)
 
DegreeMaster of Public Health
 
SubjectProtein kinases - Inhibitors - Therapeutic use.
Liver - Cancer - Mortality.
Cancer - Patients
 
Dept/ProgramPublic Health
 
DOIhttp://dx.doi.org/10.5353/th_b4694286
 
DC FieldValue
dc.contributor.authorWong, Carmen
 
dc.contributor.author黃嘉敏
 
dc.date.hkucongregation2011
 
dc.date.issued2011
 
dc.description.naturepublished_or_final_version
 
dc.description.thesisdisciplinePublic Health
 
dc.description.thesislevelmaster's
 
dc.description.thesisnameMaster of Public Health
 
dc.identifier.doihttp://dx.doi.org/10.5353/th_b4694286
 
dc.identifier.hkulb4694286
 
dc.languageeng
 
dc.publisherThe University of Hong Kong (Pokfulam, Hong Kong)
 
dc.relation.ispartofHKU Theses Online (HKUTO)
 
dc.rightsThe author retains all proprietary rights, (such as patent rights) and the right to use in future works.
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
 
dc.source.urihttp://hub.hku.hk/bib/B46942865
 
dc.subject.lcshProtein kinases - Inhibitors - Therapeutic use.
 
dc.subject.lcshLiver - Cancer - Mortality.
 
dc.subject.lcshCancer - Patients
 
dc.titleA systematic review of the drug sorafenib in extending survival time in patients with hepatocellular carcinoma
 
dc.typePG_Thesis
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Wong, Carmen</contributor.author>
<contributor.author>&#40643;&#22025;&#25935;</contributor.author>
<date.issued>2011</date.issued>
<language>eng</language>
<publisher>The University of Hong Kong (Pokfulam, Hong Kong)</publisher>
<relation.ispartof>HKU Theses Online (HKUTO)</relation.ispartof>
<rights>The author retains all proprietary rights, (such as patent rights) and the right to use in future works.</rights>
<rights>Creative Commons: Attribution 3.0 Hong Kong License</rights>
<source.uri>http://hub.hku.hk/bib/B46942865</source.uri>
<subject.lcsh>Protein kinases - Inhibitors - Therapeutic use.</subject.lcsh>
<subject.lcsh>Liver - Cancer - Mortality.</subject.lcsh>
<subject.lcsh>Cancer - Patients</subject.lcsh>
<title>A systematic review of the drug sorafenib in extending survival time in patients with hepatocellular carcinoma</title>
<type>PG_Thesis</type>
<identifier.hkul>b4694286</identifier.hkul>
<description.thesisname>Master of Public Health</description.thesisname>
<description.thesislevel>master&apos;s</description.thesislevel>
<description.thesisdiscipline>Public Health</description.thesisdiscipline>
<description.nature>published_or_final_version</description.nature>
<identifier.doi>10.5353/th_b4694286</identifier.doi>
<date.hkucongregation>2011</date.hkucongregation>
<bitstream.url>http://hub.hku.hk/bitstream/10722/145770/3/FullText.pdf</bitstream.url>
</item>